Report Detail

Medical Devices & Consumables Global Colorectal Cancer Molecular Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030

  • RnM4618237
  • |
  • 26 September, 2024
  • |
  • Global
  • |
  • 86 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Medical Devices & Consumables

According to our (Global Info Research) latest study, the global Colorectal Cancer Molecular Diagnostics market size was valued at US$ 704 million in 2023 and is forecast to a readjusted size of USD 1727 million by 2030 with a CAGR of 13.8% during review period.
Global core colorectal cancer molecular diagnostics players include Roche Diagnostics, Abbott and Thermo Fisher etc. The top 3 companies hold a share about 45%. Middle East and Africa is the largest market with a share about 43%, followed by Asia-Pacific and Europe.
In terms of product, polymerase chain reaction PCR is the largest segment with a share about 50%. And in terms of applications, the largest application is third-party testing agency with a share about 48%.
This report is a detailed and comprehensive analysis for global Colorectal Cancer Molecular Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.
Key Features:
Global Colorectal Cancer Molecular Diagnostics market size and forecasts, in consumption value ($ Million), 2019-2030
Global Colorectal Cancer Molecular Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2019-2030
Global Colorectal Cancer Molecular Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2019-2030
Global Colorectal Cancer Molecular Diagnostics market shares of main players, in revenue ($ Million), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Colorectal Cancer Molecular Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Colorectal Cancer Molecular Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Diagnostics, Abbott, Thermo Fisher, Qiagen, Illumina, Biomerieux, Bio-Rad, Agilent, Daangene, Amoydx, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Colorectal Cancer Molecular Diagnostics market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segmentation
Colorectal Cancer Molecular Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Polymerase Chain Reaction PCR
Molecular Hybridization
Biochip
Others
Market segment by Application
Hospital
Third-Party Testing Agency
Others
Market segment by players, this report covers
Roche Diagnostics
Abbott
Thermo Fisher
Qiagen
Illumina
Biomerieux
Bio-Rad
Agilent
Daangene
Amoydx
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Colorectal Cancer Molecular Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Colorectal Cancer Molecular Diagnostics, with revenue, gross margin, and global market share of Colorectal Cancer Molecular Diagnostics from 2019 to 2024.
Chapter 3, the Colorectal Cancer Molecular Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Colorectal Cancer Molecular Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2024 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Colorectal Cancer Molecular Diagnostics.
Chapter 13, to describe Colorectal Cancer Molecular Diagnostics research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Colorectal Cancer Molecular Diagnostics by Type
    • 1.3.1 Overview: Global Colorectal Cancer Molecular Diagnostics Market Size by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Global Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Type in 2023
    • 1.3.3 Polymerase Chain Reaction PCR
    • 1.3.4 Molecular Hybridization
    • 1.3.5 Biochip
    • 1.3.6 Others
  • 1.4 Global Colorectal Cancer Molecular Diagnostics Market by Application
    • 1.4.1 Overview: Global Colorectal Cancer Molecular Diagnostics Market Size by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Hospital
    • 1.4.3 Third-Party Testing Agency
    • 1.4.4 Others
  • 1.5 Global Colorectal Cancer Molecular Diagnostics Market Size & Forecast
  • 1.6 Global Colorectal Cancer Molecular Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global Colorectal Cancer Molecular Diagnostics Market Size by Region: 2019 VS 2023 VS 2030
    • 1.6.2 Global Colorectal Cancer Molecular Diagnostics Market Size by Region, (2019-2030)
    • 1.6.3 North America Colorectal Cancer Molecular Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.4 Europe Colorectal Cancer Molecular Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.5 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.6 South America Colorectal Cancer Molecular Diagnostics Market Size and Prospect (2019-2030)
    • 1.6.7 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size and Prospect (2019-2030)

2 Company Profiles

  • 2.1 Roche Diagnostics
    • 2.1.1 Roche Diagnostics Details
    • 2.1.2 Roche Diagnostics Major Business
    • 2.1.3 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Product and Solutions
    • 2.1.4 Roche Diagnostics Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Roche Diagnostics Recent Developments and Future Plans
  • 2.2 Abbott
    • 2.2.1 Abbott Details
    • 2.2.2 Abbott Major Business
    • 2.2.3 Abbott Colorectal Cancer Molecular Diagnostics Product and Solutions
    • 2.2.4 Abbott Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Abbott Recent Developments and Future Plans
  • 2.3 Thermo Fisher
    • 2.3.1 Thermo Fisher Details
    • 2.3.2 Thermo Fisher Major Business
    • 2.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Product and Solutions
    • 2.3.4 Thermo Fisher Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Thermo Fisher Recent Developments and Future Plans
  • 2.4 Qiagen
    • 2.4.1 Qiagen Details
    • 2.4.2 Qiagen Major Business
    • 2.4.3 Qiagen Colorectal Cancer Molecular Diagnostics Product and Solutions
    • 2.4.4 Qiagen Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 Qiagen Recent Developments and Future Plans
  • 2.5 Illumina
    • 2.5.1 Illumina Details
    • 2.5.2 Illumina Major Business
    • 2.5.3 Illumina Colorectal Cancer Molecular Diagnostics Product and Solutions
    • 2.5.4 Illumina Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Illumina Recent Developments and Future Plans
  • 2.6 Biomerieux
    • 2.6.1 Biomerieux Details
    • 2.6.2 Biomerieux Major Business
    • 2.6.3 Biomerieux Colorectal Cancer Molecular Diagnostics Product and Solutions
    • 2.6.4 Biomerieux Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Biomerieux Recent Developments and Future Plans
  • 2.7 Bio-Rad
    • 2.7.1 Bio-Rad Details
    • 2.7.2 Bio-Rad Major Business
    • 2.7.3 Bio-Rad Colorectal Cancer Molecular Diagnostics Product and Solutions
    • 2.7.4 Bio-Rad Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Bio-Rad Recent Developments and Future Plans
  • 2.8 Agilent
    • 2.8.1 Agilent Details
    • 2.8.2 Agilent Major Business
    • 2.8.3 Agilent Colorectal Cancer Molecular Diagnostics Product and Solutions
    • 2.8.4 Agilent Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Agilent Recent Developments and Future Plans
  • 2.9 Daangene
    • 2.9.1 Daangene Details
    • 2.9.2 Daangene Major Business
    • 2.9.3 Daangene Colorectal Cancer Molecular Diagnostics Product and Solutions
    • 2.9.4 Daangene Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Daangene Recent Developments and Future Plans
  • 2.10 Amoydx
    • 2.10.1 Amoydx Details
    • 2.10.2 Amoydx Major Business
    • 2.10.3 Amoydx Colorectal Cancer Molecular Diagnostics Product and Solutions
    • 2.10.4 Amoydx Colorectal Cancer Molecular Diagnostics Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Amoydx Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Colorectal Cancer Molecular Diagnostics Revenue and Share by Players (2019-2024)
  • 3.2 Market Share Analysis (2023)
    • 3.2.1 Market Share of Colorectal Cancer Molecular Diagnostics by Company Revenue
    • 3.2.2 Top 3 Colorectal Cancer Molecular Diagnostics Players Market Share in 2023
    • 3.2.3 Top 6 Colorectal Cancer Molecular Diagnostics Players Market Share in 2023
  • 3.3 Colorectal Cancer Molecular Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 Colorectal Cancer Molecular Diagnostics Market: Region Footprint
    • 3.3.2 Colorectal Cancer Molecular Diagnostics Market: Company Product Type Footprint
    • 3.3.3 Colorectal Cancer Molecular Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Colorectal Cancer Molecular Diagnostics Consumption Value and Market Share by Type (2019-2024)
  • 4.2 Global Colorectal Cancer Molecular Diagnostics Market Forecast by Type (2025-2030)

5 Market Size Segment by Application

  • 5.1 Global Colorectal Cancer Molecular Diagnostics Consumption Value Market Share by Application (2019-2024)
  • 5.2 Global Colorectal Cancer Molecular Diagnostics Market Forecast by Application (2025-2030)

6 North America

  • 6.1 North America Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2019-2030)
  • 6.2 North America Colorectal Cancer Molecular Diagnostics Market Size by Application (2019-2030)
  • 6.3 North America Colorectal Cancer Molecular Diagnostics Market Size by Country
    • 6.3.1 North America Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2019-2030)
    • 6.3.2 United States Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 6.3.3 Canada Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 6.3.4 Mexico Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)

7 Europe

  • 7.1 Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2019-2030)
  • 7.2 Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2019-2030)
  • 7.3 Europe Colorectal Cancer Molecular Diagnostics Market Size by Country
    • 7.3.1 Europe Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2019-2030)
    • 7.3.2 Germany Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.3 France Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.4 United Kingdom Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.5 Russia Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 7.3.6 Italy Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)

8 Asia-Pacific

  • 8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2019-2030)
  • 8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2019-2030)
  • 8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Consumption Value by Region (2019-2030)
    • 8.3.2 China Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.3 Japan Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.4 South Korea Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.5 India Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.6 Southeast Asia Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 8.3.7 Australia Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)

9 South America

  • 9.1 South America Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2019-2030)
  • 9.2 South America Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2019-2030)
  • 9.3 South America Colorectal Cancer Molecular Diagnostics Market Size by Country
    • 9.3.1 South America Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2019-2030)
    • 9.3.2 Brazil Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 9.3.3 Argentina Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)

10 Middle East & Africa

  • 10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Type (2019-2030)
  • 10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Application (2019-2030)
  • 10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Consumption Value by Country (2019-2030)
    • 10.3.2 Turkey Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 10.3.3 Saudi Arabia Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)
    • 10.3.4 UAE Colorectal Cancer Molecular Diagnostics Market Size and Forecast (2019-2030)

11 Market Dynamics

  • 11.1 Colorectal Cancer Molecular Diagnostics Market Drivers
  • 11.2 Colorectal Cancer Molecular Diagnostics Market Restraints
  • 11.3 Colorectal Cancer Molecular Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Colorectal Cancer Molecular Diagnostics Industry Chain
  • 12.2 Colorectal Cancer Molecular Diagnostics Upstream Analysis
  • 12.3 Colorectal Cancer Molecular Diagnostics Midstream Analysis
  • 12.4 Colorectal Cancer Molecular Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Colorectal Cancer Molecular Diagnostics. Industry analysis & Market Report on Colorectal Cancer Molecular Diagnostics is a syndicated market report, published as Global Colorectal Cancer Molecular Diagnostics Market 2024 by Company, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of Colorectal Cancer Molecular Diagnostics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,208.56
    4,812.84
    6,417.12
    531,604.80
    797,407.20
    1,063,209.60
    292,702.80
    439,054.20
    585,405.60
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report